LEADER 05814nam 2201729z- 450 001 9910557546203321 005 20210501 035 $a(CKB)5400000000044145 035 $a(oapen)https://directory.doabooks.org/handle/20.500.12854/69451 035 $a(oapen)doab69451 035 $a(EXLCZ)995400000000044145 100 $a20202105d2020 |y 0 101 0 $aeng 135 $aurmn|---annan 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 00$aNovel Biomarkers for Heart Disease 210 $aBasel, Switzerland$cMDPI - Multidisciplinary Digital Publishing Institute$d2020 215 $a1 online resource (420 p.) 311 08$a3-03943-883-2 311 08$a3-03943-884-0 330 $aCardiac biomarkers such as troponins and natiuretic peptides have made a great impact on clinical decision making as well as improving our understanding of molecular mechanisms of different disease conditions. However, the biomarkers that are currently in use do not reflect all the multiple disease pathways that are involved in a broad spectrum of cardiac disease conditions ranging from acute coronary syndrome, to heart failure (and heart failure with preserved ejection fraction, HFpEF), to pulmonary hypertension or arrhythmias. In this Special Issue, we will provide an overview of the current developments in the field of biomarker research, beginning with research on molecular pathways and cellular communication (e.g., microRNA) up to the clinical use of biomarkers. 606 $aMedicine$2bicssc 610 $aacute kidney injury 610 $aacute myocardial infarction 610 $aAMI 610 $aaneurysm 610 $aaortic disease 610 $aaortic regurgitation 610 $aatrial fibrillation 610 $aatrial myopathy 610 $abiomarker 610 $abiomarkers 610 $acarbohydrate antigen-125 610 $acardiac biomarkers 610 $acardiac intensive care units 610 $acardiac magnetic resonance imaging 610 $acardiometabolic disease 610 $acardiometabolic risks 610 $acardiovascular death 610 $acardiovascular diseases 610 $acardiovascular events 610 $acardiovascular risk 610 $acardiovascular surgery 610 $acatestatin 610 $acell adhesion molecule 610 $aceramides 610 $aceruloplasmin 610 $achronic heart failure 610 $achronic kidney disease 610 $acirculating cells 610 $acirculating miRNAs 610 $aCKD 610 $acohort studies 610 $acoronary artery disease 610 $aCVD 610 $adiet quality 610 $aechocardiography 610 $aejection fraction 610 $aepicardial adipose tissue 610 $aepicardial fat 610 $aepicardial fat volume 610 $aFABP3 610 $afatty acid-binding protein 3 610 $aFramingham risk score 610 $aGDF-15 610 $aGDF8 610 $agrowth differentiation factor 15 (GDF-15) 610 $aH-FABP 610 $ahealthy eating index 610 $aheart failure 610 $aheart failure decompensation 610 $aheart-type fatty acid-binding protein 610 $aheart-type fatty acid-binding protein (H-FABP) 610 $aherat failure 610 $aHF 610 $aHFpEF 610 $aHFrEF 610 $ahypertension 610 $ainflammatory marker 610 $aKLF4 610 $aleft ventricular adverse remodelling 610 $aleft ventricular ejection fraction 610 $aleft ventricular systolic function 610 $aliver-type fatty-acid-binding protein 610 $along-term outcomes 610 $alongitudinal strain 610 $amagnetic resonance imaging 610 $amagnetic resonance spectroscopy 610 $ametabolic syndrome 610 $amicroRNA 610 $amiRNA 610 $amitochondrial DNA (mtDNA) 610 $amitochondrial dysfunction 610 $amuscle wasting 610 $amyocardial infarction 610 $amyocardial triglyceride content 610 $amyostatin 610 $an/a 610 $aNAFLD 610 $aNAFLD fibrosis score 610 $aNT-proBNP 610 $aNYHA functional class 610 $aobesity 610 $aolder women 610 $aoperative risk 610 $aoxidative stress 610 $aPBMCS 610 $aPentraxin-3 610 $aplatelets 610 $aPPCI 610 $apregnancy-associated plasma protein-A 610 $aprimary prevention 610 $areactive oxygen species (ROS) 610 $arenal dysfunction 610 $arepeated measurements 610 $arisk prediction 610 $arisk stratification 610 $asaliva 610 $asalivary biomarkers 610 $asarcopenia 610 $asecondary prevention 610 $aSOCE 610 $asoluble suppression of tumorigenicity 2 (sST2) 610 $asoluble urokinase-type plasminogen activator receptor (suPAR) 610 $asST2 610 $aSTEMI 610 $aSTIM1 610 $asudden cardiac death 610 $asuPAR 610 $asynthetic phenotype 610 $aT1 mapping 610 $aTGF-? pathway 610 $athyroid-stimulating hormone 610 $atroponin 610 $avena contracta area 610 $aventricular arrhythmia 610 $aventricular tachycardia 610 $avery low-density lipoprotein 615 7$aMedicine 700 $aLichtenauer$b Michael$4edt$01287943 702 $aLichtenauer$b Michael$4oth 906 $aBOOK 912 $a9910557546203321 996 $aNovel Biomarkers for Heart Disease$93020593 997 $aUNINA